Pharma & Life Sciences · Vertical Intelligence

From R&D Dark Matter
to Audit-Ready Intelligence

Your most valuable IP is trapped in handwritten batch records, thousand-page eCTD submissions, and non-standardised lab notebooks. Intics ADI transforms it into a sovereign, high-velocity strategic asset — without ever leaving your firewall.

For regulatory affairs, quality, and R&D leaders who need to move faster without compromising GxP compliance.

95%
Field-level extraction accuracy across clinical documents
<11mo
Typical break-even vs. manual QA and SaaS processing fees
50+
Regulatory jurisdictions supported for international filings
90-day
Proof-of-value pilot to first measurable ROI
The Problem

Pharma knowledge is
buried in “Dark Matter”

The average pharmaceutical company processes millions of documents per year — batch records in technical cursive, non-standardised lab notebooks, sprawling eCTD submissions. This data is your most valuable IP, yet it’s invisible to your systems, your auditors, and your leadership.

01 / The Scale Challenge

Clinical trial files, batch records, SOPs, and lab notes exist as static PDFs, scans, and handwritten forms. Senior scientists spend up to 30% of their time manually locating and re-keying data that already exists somewhere in your document estate.

02 / The Sovereignty Risk

Cloud-based AI services require your compound data, patient narratives, and formulation specifics to leave your perimeter. A single breach or vendor policy change can expose multi-billion dollar pipeline IP. “Rented AI” is an existential risk in pharma.

03 / The Compliance Trap

Semantic inconsistencies across eCTD modules — caught only at FDA/EMA review — result in months of delays and direct financial penalties. Manual cross-checking across thousand-page dossiers is error-prone and chronically understaffed.

04 / The Hidden Cost

As your document volumes grow — more trials, more markets, more products — your processing costs grow proportionally. You pay more precisely when your business is most active. This is a structural misalignment that owned infrastructure eliminates.

How It Works

From ingestion to action — fully within your perimeter

Intics ADI operates as an intelligence layer on top of your existing TMF, ERP, and QMS systems. No rip-and-replace. No cloud dependency. No per-page fees.

01
Ingest any document format

Handwritten batch records, scanned lab notebooks, eCTD PDFs, CRFs, CSRs — any format, any quality, any language.

02
Domain-trained vision models

Radon, Xenon, and Krypton models — specifically trained on pharma document types — extract with clinical precision.

03
Agentic validation loops

AI agents perform cross-document consistency checks: eCTD module cross-referencing, TMF reconciliation, MEDDRA coding.

04
Structured output to your systems

Validated data feeds directly into your QMS, ERP, TMF, or regulatory submission platform via API or structured file.

05
Immutable audit trail

Every extraction linked to source bounding box. Every agentic decision logged. Always audit-ready for 21 CFR Part 11.

→ 95% zero-touch. Human review only for edge cases.
Purpose-Built Intelligence

Three models trained on
your document reality

General-purpose AI models fail on pharma documents because they were never trained on technical cursive, complex table structures, or regulatory filing conventions. Intics deploys domain-specific vision models built for the documents you actually have.

Radon · Vision-First
Handwritten & degraded document specialist

Trained on technical cursive, low-quality scans, and degraded originals. Reads batch records signed by laboratory technicians with the same precision as typed documents. The model that unlocks your “dark matter.”

Batch recordsLab notebooksSite logs
Xenon · Clinical NLP
Clinical narrative & adverse event specialist

Understands clinical intent within patient narratives, physician notes, and safety reports. Extracts adverse event signals, suspect drugs, and clinical symptoms — then cross-references MedDRA codes automatically.

Patient narrativesCSRsICSRs
Krypton · Structured Data
Complex table & specification specialist

Identifies table structure and spatial relationships within CMC dossiers, Certificates of Analysis, and regulatory filings. Maps extracted data to your internal taxonomy automatically.

CoAsCMC dossierseCTD modules
Strategic Use Cases

Where Intics delivers measurable outcomes

Eight high-value workflows — from eCTD submission to pharmacovigilance — each with documented performance outcomes. Start with the one that has the most immediate impact on your pipeline.

Clinical Operations
TMF Autopilot

Autonomous agents monitor TMF repositories (Veeva, SharePoint) in real time, performing semantic reconciliation against study protocol. “Always audit-ready” status — no manual TMF review cycles.

✓ Eliminates manual TMF review cycles
Regulatory Affairs
eCTD Semantic Audit

Cross-document consistency checks across all five eCTD modules before submission. Catches the semantic inconsistencies that cause Refusal to File — before you submit to FDA or EMA.

✓ Prevents multi-million dollar RTF delays
Pharmacovigilance
AE Intake Automation

Xenon extracts patient data, suspect drugs, and clinical symptoms from adverse event reports. Cross-references MedDRA codes and auto-populates ICSR fields with 95%+ accuracy.

↓ 70% reduction in case processing time
Manufacturing & CMC
GxP Batch Record Digitisation

Technical cursive models digitise complex tables and signatures in batch records. Extracts specs, test results, and deviation records from CoAs for GMP compliance tracking.

↓ 15–20% reduction in time-to-market per batch
Quality Management
CAPA & Deviation Intelligence

Agents categorise quality events, identify deviation trends across your QMS, and draft initial CAPA investigation reports. Transforms reactive quality management into proactive oversight.

↓ 40% faster deviation resolution
R&D Intelligence
Lab Notebook Semantic Index

Digitises and semantically indexes decades of lab notes, allowing researchers to query compound interaction history across your entire R&D archive. Unlocks the “dark matter” of your pipeline.

✓ R&D IP becomes searchable and queryable
Supplier Quality
Supplier Quality Agreement Analysis

Extracts GxP obligations and audit rights from vendor contracts. Flags non-conformances, tracks CAPAs, and mitigates third-party risk across your supply chain.

✓ Mitigates third-party supply risk
Medical Affairs
MSL Field Intelligence

Extracts insights from field visit reports, KOL interaction records, and medical inquiry responses. Surfaces patterns across your medical affairs activity that would otherwise remain siloed.

✓ Systematic KOL insight capture
Not seeing your use case?
We configure to your workflow

Every Intics deployment is tuned to your specific document types, taxonomy, and downstream systems. Book a Dark Matter Discovery session to map your document estate.

Platform Demo

See ADI process a batch record in real time

Watch Intics ingest a handwritten GMP batch record — technical cursive and all — and produce structured, audit-ready output in under 60 seconds. No pre-processing. No templates.

Batch record ingestioneCTD cross-checkTMF reconciliation

Interactive product demo also available — contact your Intics representative

Pharma ADI Platform Walkthrough 8 minutes · GxP document intelligence
Industry Proof Points

Outcomes from production deployments

Results from anonymised enterprise pharma deployments across clinical operations, CMC, and pharmacovigilance workflows.

18%
Reduction in batch-to-market cycle time at a global generics manufacturer — achieved within 90 days of production deployment.
70%
Reduction in ICSR case processing time at a top-20 pharmaceutical company, enabling the pharmacovigilance team to handle 3× the case volume.
0
Refusal to File events following eCTD semantic audit deployment across three consecutive NDA submissions to FDA — vs. two RTFs in the prior 24 months.
The Economics

Stop paying a per-page tax on your own IP

As your pipeline grows — more trials, more markets, more products — your cloud processing costs grow in lockstep. Intics builds you a captive infrastructure where every additional document processed has near-zero marginal cost.

Rented AI (SaaS)

Your IP leaves the firewall on every call

Per-page fees scale with your pipeline success

Vendor policy risk on data handling

No institutional learning — model doesn’t improve on your data

Owned AI (Intics)

Fully sovereign — data never leaves your perimeter

Fixed infrastructure — near-zero marginal cost per document

CapEx ownership — capitalise as an infrastructure asset

Continuous learning on your document estate

<11mo
Typical break-even, replacing manual QA labour and SaaS processing fees
3mo
From pilot kick-off to measurable ROI on a high-value workflow
95%
Zero-touch processing target — human review reserved for genuine edge cases only
Compliance & Governance

Built for the regulatory reality of pharma

Compliance is not a feature we added — it’s the architecture. Every Intics deployment in pharma is designed from the ground up to satisfy the most stringent regulatory scrutiny.

21 CFR Part 11
Electronic Records & Signatures

Full technical controls for electronic records and signatures: system-generated audit trails, user authentication and access controls, timestamped versioning, and immutable record storage. Every extraction is linked to its source document bounding box — providing the evidentiary chain an FDA auditor requires.

GxP Standards
GCP · GMP · GLP Alignment

Intics is designed for the rigour of Good Clinical, Manufacturing, and Laboratory Practices. Agentic decisions are logged with full “chain of thought” reasoning for regulatory review. Human-in-the-loop review is built into the workflow for every flagged edge case — not retrofitted.

Data Sovereignty
Air-Gapped & On-Premise Deployment

Intics supports fully sovereign, air-gapped installations for the most sensitive R&D environments. Patient PII is masked at the point of ingestion via field-level data protection. No patient data, compound data, or formulation specifics leave your defined perimeter — contractually and architecturally.

International Filing
Multi-Jurisdiction Regulatory Support

Intics processes and validates documents across 50+ regulatory jurisdictions — FDA, EMA, CDSCO, PMDA, and beyond. Regulatory intelligence agents monitor guidance updates across all active jurisdictions and trigger labelling reviews when changes affect your approved indications.

Frequently Asked Questions

Questions your legal and compliance team will ask

Is patient data sent to an external model or cloud service at any point?
No. Intics is deployed entirely within your perimeter — on-premise or in your private cloud (VPC). Patient PII is masked at the point of ingestion using field-level data protection. No patient data, compound information, or formulation specifics are transmitted to external services under any circumstances. This is enforced architecturally, not just contractually.
Can Intics read technical cursive and messy site handwriting?
Yes. The Radon model was specifically trained on “technical cursive” — the notation style common in clinical and laboratory settings, including signatures, annotations, and corrections on batch manufacturing records. It handles low-quality scans, degraded originals, and non-standard handwriting with production-grade accuracy.
Does Intics replace our current TMF or QMS system?
No — and this is by design. Intics operates as an intelligence layer on top of your existing TMF (Veeva, SharePoint, etc.) and QMS. It reads from, enriches, and writes back to your existing systems via API. There is no rip-and-replace, no data migration, and no disruption to current workflows during deployment.
How does Intics prevent Refusal to File events?
Intics agents perform pre-submission semantic consistency checks across all five eCTD modules — catching the cross-document contradictions, missing references, and formatting violations that trigger RTF letters from the FDA and EMA. This is a systematic, automated review that would take a team of regulatory writers weeks to complete manually.
What does the 90-day pilot involve, and what can we expect?
The pilot begins with a “Dark Matter Discovery” session to map your document estate and identify the highest-ROI workflow. We then deploy against a defined document set within your environment, configure extraction models to your taxonomy, and deliver a measurable outcome report at 30, 60, and 90 days. Most pilots demonstrate positive ROI before the 90-day mark.
What is the human-in-the-loop ratio at full deployment?
At our target Level 3 Autonomy, 95% of documents are processed zero-touch — extraction, validation, and downstream system update — without human intervention. The remaining 5% are flagged for human review based on confidence scores, document quality, or regulatory sensitivity thresholds you define. The system learns from every human review to improve future accuracy.

Ready to discover what’s
trapped in your document estate?

The first step is a Dark Matter Discovery session — a structured 2-hour workshop to map your document estate, identify the highest-ROI workflows, and define your pilot scope.

Book a Dark Matter Discovery Session →Download the Pharma Blueprint

Typical pilot launch: 3 weeks from discovery session